Pharmacokinetics and pharmacodynamics of inorganic nitrate in heart failure with preserved ejection fraction

Circulation Research

Volumn 120, Issue 7, 2017, Pages 1151-1161

  Zamani, Payman ^a   Tan, Victor ^a   Soto Calderon, Haideliza ^a   Beraun, Melissa ^a   Brandimarto, Jeffrey A ^a   Trieu, Lien ^b   Varakantam, Swapna ^a   Doulias, Paschalis Thomas ^c   Townsend, Raymond R ^d   Chittams, Jesse ^e   Margulies, Kenneth B ^a   Cappola, Thomas P ^a   Poole, David C ^f   Ischiropoulos, Harry ^c   Chirinos, Julio A ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b UMDNJ School of Osteopathic Medicine   (United States)

^c CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f KANSAS STATE UNIVERSITY   (United States)

Author keywords

exercise capacity; heart failure; nitric oxide

Indexed keywords

NITRIC OXIDE; POTASSIUM CHLORIDE; POTASSIUM NITRATE; NITRIC ACID DERIVATIVE; POTASSIUM DERIVATIVE;

ACTIMETRY; ADULT; ARTICLE; AUGMENTATION INDEX; BLOOD PRESSURE; CLINICAL ARTICLE; COMORBIDITY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG HALF LIFE; DRUG SAFETY; DRUG TOLERABILITY; ECHOCARDIOGRAPHY; EXERCISE; EXERCISE TEST; FEMALE; FUNCTIONAL STATUS; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; HYPOTENSION; IMPEDANCE; MALE; METABOLITE; METHEMOGLOBINEMIA; MITOCHONDRIAL RESPIRATION; OBESITY; ORTHOSTATIC BLOOD PRESSURE; OXYGEN CONSUMPTION; PRIORITY JOURNAL; QUALITY OF LIFE; REST; SKELETAL MUSCLE; STEADY STATE; SYSTOLIC BLOOD PRESSURE; TONOMETRY; TREATMENT DURATION; AGED; CONTROLLED STUDY; HEART FAILURE; HEART STROKE VOLUME; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL;

AGED; EXERCISE; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; NITRATES; POTASSIUM COMPOUNDS; QUALITY OF LIFE; STROKE VOLUME;

EID: 85007241853     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.116.309832     Document Type: Article

References (36)

1. Steinberg BA, Zhao X, Heidenreich PA, Peterson ED, Bhatt DL, Cannon CP, Hernandez AF, Fonarow GC, Get With the Guidelines Scientific Advisory C, Investigators Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction: Prevalence, therapies, and outcomes. Circulation 2012 126 65 75
2. Tsao CW, Lyass A, Larson MG, Vasan RS, Abstract 23: Divergent temporal trends in the incidence of heart failure with preserved and reduced ejection fraction. Circulation 2015 131 A23
3. van Heerebeek L, Hamdani N, Falcão-Pires I, Leite-Moreira AF, Begieneman MP, Bronzwaer JG, van der Velden J, Stienen GJ, Laarman GJ, Somsen A, Verheugt FW, Niessen HW, Paulus WJ, Low myocardial protein kinase G activity in heart failure with preserved ejection fraction. Circulation 2012 126 830 839. doi: 10.1161/CIRCULATIONAHA.111.076075.
4. Franssen C, Chen S, Unger A, Korkmaz HI, De Keulenaer GW, Tschöpe C, Leite-Moreira AF, Musters R, Niessen HW, Linke WA, Paulus WJ, Hamdani N, Myocardial microvascular inflammatory endothelial activation in heart failure with preserved ejection fraction. JACC Heart Fail 2016 4 312 324. doi: 10.1016/j.jchf.2015.10.007.
5. Redfield MM, Anstrom KJ, Levine JA, NHLBI Heart Failure Clinical Research Network Isosorbide mononitrate in heart failure with preserved ejection fraction. N Engl J Med 2015 373 2314 2324. doi: 10.1056/NEJMoa1510774.
6. Redfield MM, Chen HH, Borlaug BA, RELAX Trial Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial. JAMA 2013 309 1268 1277. doi: 10.1001/jama.2013.2024.
7. Lundberg JO, Weitzberg E, Gladwin MT, The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics. Nat Rev Drug Discov 2008 7 156 167. doi: 10.1038/nrd2466.
8. Liu C, Wajih N, Liu X, Mechanisms of human erythrocytic bioactivation of nitrite. J Biol Chem 2015 290 1281 1294. doi: 10.1074/jbc.M114.609222.
9. Maher AR, Milsom AB, Gunaruwan P, Abozguia K, Ahmed I, Weaver RA, Thomas P, Ashrafian H, Born GV, James PE, Frenneaux MP, Hypoxic modulation of exogenous nitrite-induced vasodilation in humans. Circulation 2008 117 670 677. doi: 10.1161/CIRCULATIONAHA.107.719591.
10. Modin A, Björne H, Herulf M, Alving K, Weitzberg E, Lundberg JO, Nitrite-derived nitric oxide: a possible mediator of 'acidic-metabolic' vasodilation. Acta Physiol Scand 2001 171 9 16. doi: 10.1046/j.1365-201X.2001.00771.x.
11. Cosby K, Partovi KS, Crawford JH, Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation. Nat Med 2003 9 1498 1505. doi: 10.1038/nm954.
12. Jones AM, Dietary nitrate supplementation and exercise performance. Sports Med 2014 44 suppl 1 S35 S45. doi: 10.1007/s40279-014-0149-y.
13. Ferguson SK, Glean AA, Holdsworth CT, Wright JL, Fees AJ, Colburn TD, Stabler T, Allen JD, Jones AM, Musch TI, Poole DC, Skeletal muscle vascular control during exercise: impact of nitrite infusion during nitric oxide synthase inhibition in healthy rats. J Cardiovasc Pharmacol Ther 2016 21 201 208. doi: 10.1177/1074248415599061.
14. Glean AA, Ferguson SK, Holdsworth CT, Colburn TD, Wright JL, Fees AJ, Hageman KS, Poole DC, Musch TI, Effects of nitrite infusion on skeletal muscle vascular control during exercise in rats with chronic heart failure. Am J Physiol Heart Circ Physiol 2015 309 H1354 H1360. doi: 10.1152/ajpheart.00421.2015.
15. Ferguson SK, Holdsworth CT, Colburn TD, Wright JL, Craig JC, Fees A, Jones AM, Allen JD, Musch TI, Poole DC, Dietary nitrate supplementation: impact on skeletal muscle vascular control in exercising rats with chronic heart failure. J Appl Physiol (1985) 2016 121 661 669. doi: 10.1152/japplphysiol.00014.2016.
16. Ferguson SK, Hirai DM, Copp SW, Holdsworth CT, Allen JD, Jones AM, Musch TI, Poole DC, Impact of dietary nitrate supplementation via beetroot juice on exercising muscle vascular control in rats. J Physiol 2013 591 547 557. doi: 10.1113/jphysiol.2012.243121.
17. Colburn TD, Ferguson SK, Holdsworth CT, Craig JC, Musch TI, Poole DC, Effect of sodium nitrite on local control of contracting skeletal muscle microvascular oxygen pressure in healthy rats. J Appl Physiol 2016 jap 00367 02016. doi: 10.1152/japplphysiol.00367.2016.
18. Poole DC, Hirai DM, Copp SW, Musch TI, Muscle oxygen transport and utilization in heart failure: implications for exercise (in)tolerance. Am J Physiol Heart Circ Physiol 2012 302 H1050 H1063. doi: 10.1152/ajpheart.00943.2011.
19. Zamani P, Rawat D, Shiva-Kumar P, Geraci S, Bhuva R, Konda P, Doulias PT, Ischiropoulos H, Townsend RR, Margulies KB, Cappola TP, Poole DC, Chirinos JA, Effect of inorganic nitrate on exercise capacity in heart failure with preserved ejection fraction. Circulation 2015 131 371 380; discussion 380. doi: 10.1161/CIRCULATIONAHA.114.012957.
20. Eggebeen J, Kim-Shapiro DB, Haykowsky M, Morgan TM, Basu S, Brubaker P, Rejeski J, Kitzman DW, One week of daily dosing with beetroot juice improves submaximal endurance and blood pressure in older patients with heart failure and preserved ejection fraction. JACC Heart Fail 2016 4 428 437. doi: 10.1016/j.jchf.2015.12.013.
21. Russell SD, McNeer FR, Beere PA, Logan LJ, Higginbotham MB, Improvement in the mechanical efficiency of walking: an explanation for the "placebo effect" seen during repeated exercise testing of patients with heart failure. Duke University Clinical Cardiology Studies (DUCCS) Exercise Group. Am Heart J 1998 135 107 114
22. Haddy FJ, Vanhoutte PM, Feletou M, Role of potassium in regulating blood flow and blood pressure. Am J Physiol Regul Integr Comp Physiol 2006 290 R546 R552. doi: 10.1152/ajpregu.00491.2005.
23. Green CP, Porter CB, Bresnahan DR, Spertus JA, Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure. J Am Coll Cardiol 2000 35 1245 1255
24. Nagueh SF, Appleton CP, Gillebert TC, Marino PN, Oh JK, Smiseth OA, Waggoner AD, Flachskampf FA, Pellikka PA, Evangelista A, Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr 2009 22 107 133. doi: 10.1016/j.echo.2008.11.023.
25. Jones AM, Ferguson SK, Bailey SJ, Vanhatalo A, Poole DC, Fiber type-specific effects of dietary nitrate. Exerc Sport Sci Rev 2016 44 53 60. doi: 10.1249/JES.0000000000000074.
26. 2 uptake kinetics, and exercise tolerance at high but not low pedal rates. J Appl Physiol (1985) 2015 118 1396 1405. doi: 10.1152/japplphysiol.01141.2014.
27. Coggan AR, Leibowitz JL, Kadkhodayan A, Thomas DP, Ramamurthy S, Spearie CA, Waller S, Farmer M, Peterson LR, Effect of acute dietary nitrate intake on maximal knee extensor speed and power in healthy men and women. Nitric Oxide 2015 48 16 21. doi: 10.1016/j.niox.2014.08.014.
28. Coggan AR, Leibowitz JL, Spearie CA, Kadkhodayan A, Thomas DP, Ramamurthy S, Mahmood K, Park S, Waller S, Farmer M, Peterson LR, Acute dietary nitrate intake improves muscle contractile function in patients with heart failure: a double-blind, placebo-controlled, randomized trial. Circ Heart Fail 2015 8 914 920. doi: 10.1161/CIRCHEARTFAILURE.115.002141.
29. Chirinos JA, Segers P, Noninvasive evaluation of left ventricular afterload: part 2: arterial pressure-flow and pressure-volume relations in humans. Hypertension 2010 56 563 570. doi: 10.1161/HYPERTENSIONAHA.110.157339.
30. Ryan TE, Southern WM, Reynolds MA, McCully KK, A cross-validation of near-infrared spectroscopy measurements of skeletal muscle oxidative capacity with phosphorus magnetic resonance spectroscopy. J Appl Physiol (1985) 2013 115 1757 1766. doi: 10.1152/japplphysiol.00835.2013.
31. Kapil V, Khambata RS, Robertson A, Caulfield MJ, Ahluwalia A, Dietary nitrate provides sustained blood pressure lowering in hypertensive patients: a randomized, phase 2, double-blind, placebo-controlled study. Hypertension 2015 65 320 327. doi: 10.1161/HYPERTENSIONAHA.114.04675.
32. Flynn KE, Piña IL, Whellan DJ, HF-ACTION Investigators Effects of exercise training on health status in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA 2009 301 1451 1459. doi: 10.1001/jama.2009.457.
33. Nolte K, Herrmann-Lingen C, Wachter R, Gelbrich G, Düngen HD, Duvinage A, Hoischen N, von Oehsen K, Schwarz S, Hasenfuss G, Halle M, Pieske B, Edelmann F, Effects of exercise training on different quality of life dimensions in heart failure with preserved ejection fraction: the Ex-DHF-P trial. Eur J Prev Cardiol 2015 22 582 593. doi: 10.1177/2047487314526071.
34. Zamani P, French B, Brandimarto JA, Doulias PT, Javaheri A, Chirinos JA, Margulies KB, Townsend RR, Sweitzer NK, Fang JC, Ischiropoulos H, Cappola TP, Effect of heart failure with preserved ejection fraction on nitric oxide metabolites. Am J Cardiol 2016 118 1855 1860. doi: 10.1016/j.amjcard.2016.08.077.
35. Gupta D, Georgiopoulou VV, Kalogeropoulos AP, Marti CN, Yancy CW, Gheorghiade M, Fonarow GC, Konstam MA, Butler J, Nitrate therapy for heart failure: benefits and strategies to overcome tolerance. JACC Heart Fail 2013 1 183 191. doi: 10.1016/j.jchf.2013.03.003.
36. Kapil V, Milsom AB, Okorie M, Maleki-Toyserkani S, Akram F, Rehman F, Arghandawi S, Pearl V, Benjamin N, Loukogeorgakis S, Macallister R, Hobbs AJ, Webb AJ, Ahluwalia A, Inorganic nitrate supplementation lowers blood pressure in humans: role for nitrite-derived NO. Hypertension 2010 56 274 281. doi: 10.1161/HYPERTENSIONAHA.110.153536.